Ark Biotech

Using the physics, chemistry, and biology of upstream cell culture, Ark's virtual bioreactor software simulates the complex interactions between biological materials and the bioreactor environment — with high predictive power.

The page describes an interface where AI agents inspect files, write code, and standardize cell culture data, while scientists make decisions using the same tools and data.

Ark uses computational tools, including high-fidelity simulation, to support data-rich decisions. Its computational bioprocess tools enable virtual experiments, process optimization, and development risk reduction.

Insights from Ark on bioprocess simulation, digital twins, and AI in biopharma. Articles on faster development and more robust manufacturing.

The FDA released draft guidance in January on using AI to support regulatory decision-making for drug and biological products. It may change after public feedback and FDA review and addresses AI use across drug development.

Ark says it fosters a culture of innovation, collaboration, and growth and lists current job openings.

Ark combines biology, chemistry, and physics with machine learning and AI in a model-first approach to bioprocessing.

Ark provides simulation models for bioprocess scientists and says they can shorten timelines, reduce experiments, and improve outcomes without engineering.

Ark's bioprocess simulation software is designed to accelerate time to market and increase throughput.

Ark Biotech's privacy policy explains how it treats personal data.

Ark Biotech's terms describe rules and restrictions governing use of its website.